… The main purpose of this study was to evaluate the clinical effect of LPV/r combined with the
routine adjuvant therapeutic drugs on patients with COVID-19. As revealed, the time of body …

… vitro animal models and clinical studies of drugs … lopinavir-ritonavir combinations. These
compounds have been frequently touted as top candidates to treat COVID-19, but recent clinical …

… plus ritonavir in combination with two nucleoside analogues is generally safe, and has
superior short-term antiviral efficacy compared with indinavir and ritonavir also combined with two …

… The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir
and ritonavir (NMV-r) for treating COVID-19 in patients with diabetes mellitus (DM). This …

… We conclude that ritonavir and saquinavir in combination are well tolerated and induce a
high and sustained antiretroviral efficacy in protease inhibitor–naive patients with CD4 cell …

… Conclusion Lopinavir/ ritonavir combined with … CT imagesꎬbut the effects on clinical symptoms
are not obviousꎬand … the safety of lopinavir/ ritonavir in clinical application. KEY WORDS …

… the pharmacologic and clinical aspects of lopinavir/ritonavir in the … Coformulated
lopinavir/ritonavir was the first combination pill … clinical efficacy with no clinical resistance to …

… against SARS-CoV-2 activity invitro, clinical efficacy is not established. In this meta-analysis, …
efficacy and safety of this combination and rationale of using this combination in COVID-19. …

… -defining clinical events 32 and has recently been licensed by the Food and Drug Administration
for the therapy of HIV infection. Ongoing clinical studies using ritonavir in combination …

… clinical efficacy of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir, both given
in combination … Here, we report the 48-week primary efficacy and safety results of this study…